Genetic alterations in leukemias and lymphomas: Impressive progress and continuing complexity

Cancer Genetics and Cytogenetics

Volumn 94, Issue 1, 1997, Pages 13-19

  Nowell, Peter C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME TRANSLOCATION; GENETIC LINKAGE; HUMAN; LEUKEMIA; LEUKEMOGENESIS; LYMPHOMA; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; REVIEW;

EID: 0030901160     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00227-0     Document Type: Article

References (52)

1. Sandberg AA, Koepf GF, Crosswhite LH, Hauschka TS (1960): The chromosome constitution of human marrow in various developmental and blood disorders. Am J Hum Genet 12:231-249.
2. Ford CE, Jacobs PA, Lajtha LG (1958): Human somatic chromosomes, Nature 181:1565-1568.
3. Nowell PC, Hungerford DA, Brooks CD (1958): Chromosomal characteristics of normal and leukemic human leukocytes after short-term culture. Proc Am Assn Cancer Res 2:331-332.
4. Baikie AG, Court Brown WM, Jacobs PA, Milne JS (1959): Chromosome studies in human leukaemia. Lancet ii:425-428.
5. Bayreuther K (1960): Chromosomes in primary neoplastic growth. Nature 186:6-9.
6. Sandberg AA (1980): The Chromosomes in Human Cancer and Leukemia. Elsevier North Holland, New York.
7. Rowley JD (1984): Biological implications of consistent chromosome rearrangements in leukemia and lymphoma. Cancer Res 44:3159-3168.
8. Rabbitts TH (1994): Chromosomal translocations in human cancer. Nature 372:143-149.
9. Solomon E, Borrow J, Goddard AD (1991): Chromosome aberrations and cancer. Science 254:1153-1160.
10. Look AT (1995): Fusion genes and their hybrid proteins in human leukemias and lymphomas. Proc Assn Am Physicians 107:175-180.
11. Barr FG (1996): The malevolence of matchmaking. Nature Genet 12:113-114.
12. Nitta M, Kato Y, Strife A, Wachter M, Fried J, Perez A, Jhanwar S, Duigou-Ostendorf R, Chaganti RSK, Clarkson B, (1985): Incidence of involvement of the B and T lymphocyte lineages in chronic myelogenous leukemia. Blood 66:1053-1061.
13. Clarkson B, Chabner BA, Weinberg RA (1995): Targets for specific therapies in leukemia. Cancer Res 55:4488-4498.
14. Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM, Dalla-Favera R (1991): p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 88:5413-5417.
15. Feinstein E, Cimino G, Gale RP, Alimena G, Berthier R, Kishi K, Goldman J, Zaccaria A, Berribi A, Canaani E (1991): p53 in chronic myelogenous leukemia in acute phase. Proc Natl Acad Sci USA 88:6293-6297.
16. Cayuela J-M, Madani A, Sanhes L, Stern M-H, Sigaux F (1996): Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia. Blood 87:2180-2186.
17. INK4B, p53, and Rb genes in primary lymphoid malignancies. Blood 87:4949-4958.
18. Heim S, Mitelman F (1995): Cancer Cytogenetics, 2nd Ed., Wiley-Liss, New York.
19. Tsujimoto Y, Finger L, Yunis J, Nowell PC, Croce CM (1984): Cloning of the chromosome breakpoint of neoplastic B-cells with the t(14;18) chromosome translocation. Science 226:1097-1099.
20. Hockenbury D, Nuñez G, Milliman C, Schreiber RD, Korsmeyer SJ (1990): bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336.
21. Reed JC (1994): Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1-6.
22. Carlesso N, Griffin JD, Druker BJ (1994): Use of a temperature-sensitive mutant to define the biological effects of the p210BCR-ABL tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line. Oncogene 9:149-156.
23. Douglas RS, Capocasale RJ, Lamb RJ, Nowell PC, Moore JS (1996): CLL B cells are resistant to the apoptotic effects of transforming growth factor-beta (TGF-β). Blood (in press).
24. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C, Nicoletti I, Pelicci PG (1993): The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423-431.
25. Chen Z, Tong J-H, Dong S, Zhu J, Wang Z-Y, Chen S-J (1996): Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia. Genes Chromosom Cancer 15:147-156.
26. German J (1974): Bloom's syndrome. II. The prototype of human genetic disorders predisposing to chromosome instability and cancer. In: Chromosomes and Cancer. J German, ed. John Wiley & Sons, New York, pp. 601-617.
27. Nowell P (1976): The clonal evolution of tumor cell populations. Science 194:23-28.
28. Loeb LA (1991): Mutator phenotype may be required for multistage repair and initiation of carcinogenesis. FASEB J 7:1188-1191.
29. Modrich P (1994): Mismatch repair, genetic stability, and cancer. Science 266:1959-1960.
30. Capocasale RJ, Lamb RJ, Vonderheid EC, Fox FE, Rook AH, Nowell PC, Moore JS (1995): Reduced surface expression of transforming growth factor-beta receptor type II in mitogen-activated T-cells from Sézary patients. Proc Natl Acad Sci USA 92:5501-5505.
31. Parsons R, Myeroff LL, Liu B, Wilson JKV, Markowitz SD, Kinzler KW, Vogelstein B (1995): Microsatellite instability and mutations of the transforming growth factor βtype II receptor gene in colorectal cancer. Cancer Res 55:5548-5550.
32. Laneuville P, Sun G, Vekemans M (1992): Clonal evolution in a myeloid cell line transformed to interleukin-3 independent growth by retroviral transduction and expression of p210bcr/abl. Blood 80:1788-1797.
33. de Jong D, Voetdijk BMH, Beverstock GC, van Ommen GJ, Willemze R, Kluin PM (1988): Activation of the c-myc oncogene in a precursor B-cell blast crisis of follicular lymphoma presenting as composite lymphoma. N Eng J Med 318:1373-1377.
34. Nowell PC, Moreau L, Growney P, Besa EC (1988): Karyotypic stability in chronic B cell leukemia. Cancer Genet Cytogenet 33:155-160.
35. Showe LC, Croce CM (1987): The role of chromosomal translocations in B- and T-cell neoplasia. Annu Rev Immunol 5:253-277.
36. Huebner K, Nagarajan L, Besa E, Angert E, Lange BJ, Cannizzaro LA, van den Berghe H, Santoli D, Finan J, Croce CM, Nowell PC (1990): Order of genes on human chromosome 5q with respect to 5q interstitial deletions. Am J Hum Genet 46:26-36.
37. Stryckmans P, Biernaux C, Sels A, Huez G (1995): Very low level of major BCR-ABL expression in blood of some healthy individuals. Blood 86:3118-3122.
38. Gill Super HJ, McCabe NR, Thirman M, Larson RA, Le Beau MM, Pedersen-Bjergaard J, Preben P, Diaz M, Rowley JD (1993): Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood 82:3705-3711.
39. Pederson-Bjergaard J, Philip P, Mortenson BT, Ersboll J, Jensen G, Panduro J, Thomsen M (1981): Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases: clinical and cytogenetic characteristics and results of in vitro culture of bone marrow and HLA typing. Blood 57:712-723.
40. Ames BN, Gold LS, Willett WC (1995): The causes and prevention of cancer. Proc Natl Acad Sci USA 92:5258-5265.
41. Canaani E, Nowell PC, Croce CM (1995): Molecular genetics of 11q23 chromosome translocations. In: Adv Cancer Res, Vol. 66. Academic Press, New York, pp. 213-233.
42. Bernard OA, Berger R (1995): Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations. Genes Chromosom Cancer 13:75-85.
43. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ (1992): A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia telangiectasia. Cell 71:587-697.
44. Little CD, Nau NM, Carney DN, Gazdar AF, Minna JD (1983): Amplification and expression of the c-myc oncogene in human lung cancer cells. Nature 306:194-196.
45. Seeger RD, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D (1985): Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastoma. N Eng J Med 313:1111-1115.
46. Caligiuri MA, Strout MP, Schichman SA, Mrózek K, Arthur DC, Herzig GP, Baer MR, Schiffer CA, Heinonen K, Knuutila S, Nousiainen T, Ruutu T, Block AMW, Schulman P, Pedersen-Bjergaard J, Croce CM, Bloomfield CD (1996): Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Res 56: 1418-1425.
47. Le Beau MM (1993): Detecting genetic changes in human tumor cells: have scientists gone fishing? Blood 81:1979-1983.
48. Lishner M, Lalkin A, Klein A, Yarkoni S, Manor Y, Fejgin M, Leytin V, Rabid M, Amiel A (1995): The BCL-1, BCL-2, and BCL-3 oncogenes are involved in chronic lymphocytic leukemia. Cancer Genet Cytogenet 85:118-123.
49. Bishop JM (1991): Molecular themes in oncogenesis. Cell 64:235-248.
50. Fearon ER, Vogelstein B (1990): A genetic model for colorectal tumorigenesis. Cell 61:759-768.
51. INK4B1. Cancer Res 56:722-727.
52. zur Hausen H (1991): Viruses in human cancers. Science 254:1167-1169.